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Abstract.  Rat Schwann cells cultured with dorsal root 
ganglion neurons in a serum-free defined medium fail 
to ensheathe or myelinate axons or assemble basal 
laminae. Replacement of defined medium with 
medium that contains human placental serum (HPS) 
and chick embryo extract (EE) results in both basal 
lamina and myelin formation. In the present study, the 
individual effects of HPS and EE on basal lamina as- 
sembly and on myelin formation by Schwann cells cul- 
tured with neurons have been examined, Some batches 
of HPS were unable to promote myelin formation in 
the absence of EE, as assessed by quantitative evalua- 
tion of cultures stained with Sudan black; such HPS 
also failed to promote basal lamina assembly, as as- 
sessed by immunofluorescence using antibodies against 
laminin, type IV collagen, and heparan sulfate pro- 
teoglycan. The addition of EE or L-ascorbic  acid with 
such HPS led to the formation of large quantities of 
myelin and to the assembly of basal laminae. Pretreat- 
ment of EE with ascorbic acid oxidase abolished the 
EE activity, whereas trypsin did not. Other batches of 
HPS were found to promote both basal lamina and 
myelin formation in the absence of either EE or ascor- 
bic acid. Ascorbic acid oxidase treatment or dialysis 
of these batches of HPS abolished their ability to pro- 
mote Schwann cell differentiation, whereas the subse- 
quent addition of ascorbic acid restored that ability. 
Ascorbic acid in the absence of serum was relatively 
ineffective  in promoting either basal lamina or myelin 
formation. Fetal bovine serum was as effective as HPS 
in allowing ascorbic acid (and several  analogs but not 
other reducing agents)  to manifest its ability to pro- 
mote Schwann  cell differentiation. We suggest that 
ascorbic acid promotes Schwann cell myelin formation 
by enabling the Schwann  cell to assemble a basal lam- 
ina, which is required for complete differentiation. 
I 
s  the peripheral nervous system, the Schwann cell (SC) ~ 
surrounds  axons  either  with  simple  cytoplasmic  en- 
sheathment or with myelin,  forming  SC-axon "units" 
comprised of  either up to 20 nonmyelinated axons or one my- 
elinated axon per SC (for reviews see Peters et al.,  1976; 
Thomas and Ochoa,  1984). Surrounding all SC-axon units 
is an endoneurial extracellular matrix, consisting of a basal 
lamina closely apposed to the surface of  the SC and an inter- 
stitial matrix rich in collagen fibrils (Thomas and Olsson, 
1984). Even during early embryogenesis SCs of developing 
peripheral  nerve are found in contact with a basal lamina 
(Cravioto, 1965; Gamble, 1966; Ochoa, 1971), and the subse- 
quent phases of SC differentiation (proliferation, axon sort- 
ing,  and ensheathment  and  myelin formation)  also  occur 
with the SCs in intimate association with their basal lamina 
(Martin and Webster, 1973; Webster et al.,  1973). 
Tissue culture techniques that allow the purification and 
recombination in vitro of the different cell types of the rat 
1.  Abbreviations  used in  this paper:  DM,  defined  medium; DM~,  DM 
supplemented with 15% serum; DMdt~, DM supplemented with 15% dia- 
lyzed serum; EE, embryo extract;  HPS,  human placental serum; HSPG, 
heparan sulfate proteoglycan;  SC, Schwann cell. 
peripheral nervous system have been used to study the ceUu- 
lar and noncellular requirements for the different phases of 
SC differentiation. It has been shown that the neuron regu- 
lates SC proliferation by means of an axonal surface mitogen 
(Salzer et al., 1980) and that the presence of neurons, but not 
fibroblasts, is necessary for SCs to assemble a complete ex- 
traceUular matrix consisting of a basal lamina and collagen 
fibrils in vitro (Bunge et al., 1980; Bunge et al., 1982a), a 
requirement possibly mediated by neuronal regulation of SC 
type IV collagen expression (Carey et al., 1983). Additional, 
nonneuronal  influences are also required  for complete SC 
differentiation in vitro. SCs growing on axons in serum-free 
defined medium (DM) proliferate in response to the axonal 
surface mitogen, yet fail to ensheathe or myelinate the axons, 
even if  maintained in this medium for several months. Under 
these conditions SCs also do not form an ultrastructurally 
detectable basal lamina (Moya et al.,  1980), although they 
do accumulate some laminin on their surfaces (Cornbrooks 
et al., 1983). Replacement of  DM with standard myelination- 
promoting medium, containing human placental serum (lIPS) 
and chick embryo extract (EE), results in rapid SC differenti- 
ation,  with detectable morphological  changes within 24 h 
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formation and basal lamina formation within 1 wk (Moya et 
al., 1980). This correlation between basal lamina formation 
and SC differentiation has led to the hypothesis that the for- 
mation of  a basal lamina is a prerequisite for full SC differen- 
tiation (Bunge et al.,  1986). 
Such a correlation has also been observed for SCs in other 
situations, both in vitro and in vivo. When cultures of neu- 
rons and SCs are grown in standard myelinating medium 
containing the proline analog cis-hydroxyproline, which in- 
terferes with the secretion of many proteins, including colla- 
gens, by SCs (Eldridge et al.,  1983), the formation of both 
basal lamina and myelin is disrupted (Copio and Bunge, 
1980). Castanospermine, an inhibitor of N-linked oligosac- 
charide processing, similarly inhibits the formation of both 
basal lamina and myelin by SCs grown with neurons in my- 
elinating medium, while leaving other aspects of differentia- 
tion (e.g., neuron-induced proliferation) unaffected (Rather et 
al., 1986). SCs of the dystrophic mutant mouse display both 
ensheathment and  myelination deficits  and  basal  lamina 
defects, particularly in peripheral nerve root regions (Brad- 
ley and Jenkison, 1973; Madrid et al.,  1975); the ensheath- 
ment and myelination  deficits are less marked in roots recov- 
ered from crush injury, which causes increased endoneurial 
extracellular matrix accumulation and a substantial improve- 
ment in the basal lamina defects (Bray et al.,  1983). 
In an attempt to better understand the connection between 
basal lamina formation and SC differentiation, we have in- 
vestigated the individual effects of serum and chick EE sup- 
plements to DM on basal lamina formation and on myelin 
formation by SCs cultured with sensory neurons. Our results 
demonstrate the central role of ascorbic acid in allowing full 
SC differentiation in culture and the remarkable linkage be- 
tween basal lamina assembly and myelin formation. Prelimi- 
nary reports of this work have appeared in abstract form (E1- 
dridge et al.,  1984, 1985). 
Materials and Methods 
Cell Culture 
SC-neuron cultures were prepared using modifications of previously pub- 
lished methods (Btmge et al., 1983). Briefly, dorsal root ganglia from 15--d 
embryonic Sprague-Dawley rats were dissociated with trypsin and plated on 
rat tail collagen-coated Aclar coverslips housed in Aclar minidishes (Bunge 
and Wood, 1973). The cultures were then exposed to three 2-3-d pulses of 
10  -5 M  5-fluorodeoxyuridine in HPS-containing medium, grown in DM 
(see below) for 7 d, seeded with 10-20 x  103 purified SCs, and maintained 
in DM for an additional 4 wk before initiating DM supplementation experi- 
ments. 
DM Supplementation 
The  serum-free DM  used in these experiments was essentially the N2 
medium (Bottenstein and Sato,  1979) with nerve growth factor described 
previously (Moya et al., 1980; Bunge et al., 1982b) but with rat transferrin 
(10 gg/mi; Jackson ImmunoReseareh Laboratories, Avondale, PA) instead 
of human transferrin, and with purified (2.5S) nerve growth factor (I00 
ng/ml; a gift from Dr. E. Johnson; Bocchini and Angeletti, 1969) instead 
of crude (7S)  nerve growth factor.  DM also contained bovine insulin (5 
ltg/ml), progesterone (20 nM), putrescine dihydrochloride (100 gM) (all 
from Sigma Chemical Co., St. Louis, MO), and sodium selenite (30 nM; 
Pfaltz & Bauer, Inc., Stamford, CT); the total protein concentration was 15.1 
~g/mi. 
Serum used for supplementation was HPS prepared from blood obtained 
locally  or,  where indicated,  FBS  (HyClone  Laboratories,  Logan,  UT) 
which was supplied with an analysis of the concentrations of some compo- 
nents (i.e., serum albumin, transferrin). In experiments where dialyzed se- 
rum was used, the serum was dialyzed aseptically against three changes of 
20 vol of a  1:1 mixture of Ham's F-12 and Dulbecco's MEM (the salt base 
of DM) at 4°C in 36 h; nondialyzed serum was stored at 4°C for the same 
period of time. 
Chick EE (Paul, 1970) was used at 10 or 15 % (vol/vol). In some experi- 
ments, chick EE was pretreated as follows. Chick EE was incubated with 
different concentrations of ascorbic acid oxidase (Sigma Chemical Co.) at 
pH 7.0, 25°C, or with 1 rng/ml trypsin (TRL3; CooperBiomedical, Inc., 
Malvern, PA) at pH 8.0, 350C,  for 1 h. Chick EE ultrafiltrates were then 
obtained by centrifuging the pretreated samples in Centricon 10 microcon- 
centrators (10 Kd nominal cutoff; Amicon Corp., Danvers, MA) at 5,000 g, 
4°C, for 5 h, and the ultrafiltrates were filter sterilized and used to prepare 
supplemented media. Fetuin (type I]I, Sigma Chemical Co.; "Pederson fe- 
tuin") was made as a 20 mg/ml stock solution in DM salt base and used at 
a final concentration of 1 mg/mi. A fresh 5 mg/mi stock solution of L-ascor- 
bic acid (Sigma Chemical Co.) in distilled water was made immediately be- 
fore each feeding and used at 1% for a final concentration of 280 IxM (50 
gg/ml), except as otherwise noted. Similarly, 100x stock solutions ofo-iso- 
ascorbic acid,  L-ascorbic acid 2-snifate,  reduced ghitathione (all  from 
Sigma Chemical Co.), and dihydroxyfumaric acid (Pfaltz &  Bauer, Inc.) 
were made in distilled water before each feeding. A  100×  stock solution 
of dehydroascorbic acid was made before each feeding by heating bis- 
dehydroascorbic acid (Pfaltz & Bauer, Inc.) at 60°C for 1.5 min in distilled 
water which had been acidified with COz  to pH 4  to obtain the water- 
soluble monomer. When necessary, media were filter sterilized using low 
protein-binding 0.22  rtm  Millex-GV filters  (Millipore  Corp.,  Bedford, 
MA). Filter sterilization of DM or supplemented DM did not adversely 
affect the results. 
Ascorbic Acid Assay 
The 2, 6-dichlorophenolindophenol  method of  Omaye et al. (1979) was used 
exactly as described, except  p-chloromercuribenzoate was omitted after de- 
termining it had no effect on assay results. L-Ascorbic acid was used as a 
standard. 
Culture Analysis 
Duplicate cultures were fed DM or various supplemented DMs for 2 wk 
(six feedings) and then analyzed as described below. Cultures were analyzed 
for basal lamina and myelin formation by cutting each coverslip in half, bi- 
secting the area containing all of the neuronal somata, and processing one 
half for myelin quantitation and the other half for double-label immunocyto- 
chemistry using antibodies to basal lamina components. In this way, for each 
medium, two independent samples were obtained for myelin quantitation 
and for immunocytochemistry. Experiments were performed a minimum of 
two, and typically three or more, times; representative experiments are 
presented in the tables and figures. 
Myelin Quantitation 
A modification of a previously published whole mount fixation and Sudan 
black staining procedure (Wood, 1976) was used to enhance the contrast be- 
tween darkly  staining myelin segments formed by meylinating SCs and 
lightly staining nonmyelinating SCs. Culture halves were fixed with 4% 
paraformaldehyde in 0.I M phosphate buffer, pH 7.4,  postlixed with 0.1% 
OsO4 in 0.1 M phosphate for I h at room temperature, stained with 0.5% 
Sudan black (Fisher Scientific Co., St. Louis, MO) in 70% ethanol for 1 h, 
destained, and mounted in glycerin jelly. 
Quantitafion of  myelin formation was accomplished  by counting the num- 
ber of myelin-associated SC nuclei ("myelin segments") per field in 60 high 
power fields (area =  0.17 mm  2) per culture half. The fields were arrayed 
at I-nun intervals as a 6  x  10 mm grid that covered the same area of each 
culture. The density of myelin in fields containing more than ~60 segments 
made accurate counting impossible; such fields were scored as 60 for cal- 
culating the average number of myelin segments per field.  The  values 
presented in Tables I-VI represent the average number of myelin segments 
per field for the duplicate cultures, normalized to 1 mm  2. Thus at higher 
values the average segments per nun  2 value was not linearly proportional 
to the actual number of segments per mm  2, and the maximum possible av- 
erage was 350. 
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Rabbit antisera to mouse laminin (Timpl et al., 1979) and to the NCI domain 
of mouse type IV collagen (Weber et al.,  1984) were gifts from Dr.  R. 
Timpl; they were found to be monospecific by immunoprecipitation from 
metabolically labeled conditioned medium of myelinating SC-neuron cul- 
tures and of rat Reichert's membrane organ cultures (see Eldridge et al., 
1986 for methods). Mouse monoclonal antibody B3 ascites fluid to rat basal 
lamina heparan sulfate proteogiycan (HSPG; Eldridge et al.,  1986) was a 
gift from Dr. C. Cornbrooks. Affinity-purified rabbit antibody to the large, 
low-density basal lamina HSPG from mouse Engelbreth-Holm-Swarm sar- 
coma (Hassell et al., 1985) was a girl from Dr. J. Hassell. Secondary anti- 
bodies used were fluorescein conjugated goat anti-rabbit and rhodamine- 
conjugated goat anti-mouse (Cappel  Laboratories,  Malvern,  PA);  these 
showed no cross-reactivity with the inappropriate species primary antibod- 
ies. Controls for staining used normal rabbit serum and mouse monoclonal 
antibody ascites fluid to rat antigen not produced in these cultures (antibody 
CI against muscle synaptic basal lamina; Sanes and Chin, 1983). All anti- 
body dilutions and culture rinses were done with L-15 containing 10% heat- 
inactivated horse serum (Gibco,  Grand Island,  NY),  and all procedures 
were carried out at room temperature except where noted. 
To double label tv~  surface/extraceUular antigens, live cultures were 
rinsed and then incubated with rabbit and mouse primary antibodies, diluted 
(1:100) together, for 30 min. After rinsing, the cultures were incubated with 
fluorescein anti-rabbit and rhodamine anti-mouse secondary antibodies, 
diluted (1:100) together, for 30 min. After rinsing the cultures were fixed 
for 20 min in 4% paraformaldehyde in 0.1  M  phosphate buffer, rinsed in 
0.1 M phosphate, and mounted in glyceroi/PBS containing an antibleaching 
agent (Citifluor Ltd., London). In some cases, where indicated, cultures 
were permeabilized before staining using 5% acetic acid/95% ethanol for 
10 min at  -20°C. 
Stained cultures were photographed using Tri-X film (Eastman Kodak 
Co., Rochester, NY) at a nominal ASA of 1600 and developed using Rodinal 
developer (Agfa-Gevaert, Teterboro, NJ). To allow comparisons of staining 
intensity, photographs of all  cultures stained with a  particular primary- 
secondary antibody pair within an experiment were exposed for the same 
length of time (typically 3-15 s). Negatives of each set were then printed 
identically. 
Results 
The 345 SC-neuron cultures used here were generated from 
dissociated embryonic rat dorsal root ganglion cultures that 
were first treated with fluorodeoxyuridine to eliminate all 
nonneuronal  cells  and  then  seeded  at  low  density  with 
purified SCs. Subsequent maintenance of the cultures in DM 
allowed the SCs to proliferate in response to an axonal sur- 
face  mitogen  (Salzer  et  al.,  1980) and  homogeneously 
repopulate the axon network, but did not enable the SCs to 
proceed to complete differentiation (basal lamina formation, 
myelination). Supplementation of DM was begun •4  wk af- 
ter seeding the cultures with SCs, at which time a full com- 
plement  of SCs  had  been  generated.  The  cultures  were 
processed for myelin quantitation and for immunocytochem- 
ical localization of basal lamina components after 2 wk in 
supplemented DM. 
Comparison of  SC-Neuron Cultures in Defined 
Medium and Standard Myelinating Medium 
SCs in SC-neuron cultures maintained in unsupplemented 
DM  displayed one  of two  morphologies,  either  flattened 
(Fig. 1 a) or highly rounded (see Fig. 5 in Carey and Bunge, 
1981), with the latter morphology associated predominantly 
with larger neurite fascicles. Most SCs contained prominent 
perinuclear granules which stained deeply with Sudan black 
and were particularly evident in flattened SCs (Fig.  1 a). 
Quantitative evaluation of the Sudan black-stained cultures 
revealed that myelin had not been formed in DM, as previ- 
ously reported (Moya et al., 1980), except in one experiment 
(out of 18)  where a  few short myelin segments were ob- 
served. 
When SC-neuron cultures were switched to standard my- 
elinating medium (Eagle's MEM containing 25% HPS, 10% 
chick EE, and nerve growth factor; Moya et al.,  1980), the 
rounded SCs rapidly elongated along the neurite fascicle and 
became less prominent, as described by Carey and Bunge 
(1981). By the end of the 2-wk supplementation period, the 
perinuclear  granules  prominent  in  SCs  in  DM  were  no 
longer detectable in most Sudan black-stained preparations 
(Fig.  1 b) and very substantial amounts of myelin had been 
formed. In eight experiments, cultures in standard myelinat- 
ing  medium  contained  an  average  of  280  myelin  seg- 
ments/mm  ~ (SEM  =  5),  whereas  cultures  maintained in 
DM  contained  an  average  of 0.12 myelin segments/mm  2 
(SEM  =  0.1). 
The deposition of basal lamina components by SCs cul- 
tured  with  neurons  in  DM  or  in  standard  myelinating 
medium was dramatically different, as assessed by indirect 
immunofluorescence of living, nonpermeabilized cultures. 
Cultures  in  standard  myelinating  medium  were  stained 
brightly with antibody to laminin in a  pattern continuous 
along SC surfaces (Fig. 2 f), whereas cultures in DM ap- 
peared to have little or no staining when identical photo- 
Figure 1. Sudan  black-stained SC-neuron cultures grown in DM (a) or in standard myelinating medium for 2 wk (b). Culture in DM 
shows prominent darkly stained perinuclear granules and no myelin, whereas culture in standard myelinating medium shows numerous 
darkly stained myelin segments (arrowheads). Bar, 50 ~tm. 
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myelinating medium (e-h) or DM supplemented with 15% dialyzed FBS plus ascorbic acid (i-l). The two left-hand columns show cul- 
tures stained in the living state with rabbit anti-laminin followed by fiuorescein goat anti-rabbit,  using phase-contrast (a, e, and i) and 
fluorescein (b, f, and j) optics. The two fight-hand columns show cultures doubly stained in the living state with rabbit anti-NC1 and 
mouse anti-HSPG  followed by fluorescein goat anti-rabbit  and rhodamine goat anti-mouse,  using fluorescein anti-NC1 (c, g, and k) 
and rhodamine anti-HSPG  (d, h, and 1) optics. The figures in each column were photographed and printed identically. Bar, 50 Ixm. 
graphic exposures were compared (Fig. 2, b and  f). By using 
exposure times five times longer than those in Fig. 2, how- 
ever, it was possible to observe that the surfaces of all SCs 
in DM were specifically stained in a punctate pattern with 
laminin antibody (Fig. 3 a), as previously reported (Corn- 
brooks et al.,  1983).  Staining of SCs in DM by both mouse 
monoclonal antibody and afffinity-purified rabbit antibody to 
basal lamina HSPG was similar to that of anti-laminin in that 
staining was punctate (Fig. 3 e) and faint in comparison with 
cultures grown in standard myelinating medium (compare 
Fig. 2, d and h). In contrast, rabbit antiserum to the NC1 do- 
main of type IV collagen did not stain any extracellular com- 
ponents in DM cultures (Figs.  2  c  and 3  c), although the 
antibody intensely stained cultures grown in standard my- 
elinating medium (Fig.  2 g). 
To determine whether SCs in DM were expressing type IV 
collagen but not depositing it on their surfaces, cultures were 
permeabilized with acid/alcohol before immunofluorescence 
staining. As shown in Fig. 3 d, no intracellular type IV colla- 
gen was  detectable,  whereas both laminin  (Fig.  3  b)  and 
HSPG (Fig. 3f) could be localized to the perinuclear region 
of the SC  cytoplasm.  Thus,  while SCs  grown in DM  ex- 
pressed both laminin and the basal lamina HSPG and accu- 
mulated small amounts of these molecules on their surfaces, 
they did not organize them into the linear arrangement char- 
acteristic of basal laminae of differentiated SCs in standard 
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Living (top row) or permeabilized  (bottom row) cultures  were stained with rabbit anti-laminin (a and b), rabbit anti-NC1 (c and d), 
rabbit anti-HSPG (e and f), or normal rabbit serum (g and h) followed by fluorescein goat anti-rabbit and then photographed and printed 
identically.  Exposure  times for these photographs  were five times longer than for those in Fig.  2.  Bar,  25 Ixm. 
myelinating medium, and they failed to express or accumu- 
late type IV collagen.  These results are consistent with the 
observation that SCs in DM do not have an ultrastructurally 
detectable basal lamina (Moya et al.,  1980). 
Ascorbic Acid Is a Specific Requirement for 
Schwann Cell Differentiation 
The mechanism by which standard myelinating medium acts 
to promote SC differentiation was investigated by manipula- 
tions of its complex components, HPS and chick EE.  The 
results indicate that both ascorbic acid and a nondialyzable 
serum factor are essential for normal basal lamina and my- 
elin formation by SCs. 
As shown in Table I, SC-neuron cultures given DM sup- 
plemented with HPS at  15%  (DMts)  for 2  wk accrued es- 
sentially no myelin.  Such cultures  showed little change in 
morphology from DM cultures  and showed the same pat- 
terns of staining with basal lamina antibodies as cultures in 
DM;  anti-NC1  did  not  stain,  whereas  anti-laminin  and 
anti-HSPG staining was light and punctate (data not shown). 
The addition of EE to DM~ led to substantial myelin for- 
mation by SCs (Table I) and also to the deposition of type 
IV collagen, laminin, and HSPG in the linear pattern charac- 
teristic of cultures in standard myelinating medium. It was 
found that ascorbic acid could substitute for chick EE. The 
addition of 50 ~tg/ml ascorbic acid to DMts resulted in the 
formation of myelin in quantities  comparable to those ob- 
tained in standard myelinating medium (Table I).  Further- 
more, ascorbic acid, like chick EE, promoted the deposition 
of type IV collagen, laminin, and HSPG on the SC surface, 
Table L Ascorbic Acid Mimics the Effects of  Embryo 
Extract on Schwann Cell Differentiation 
Myelin 
Medium  segmants/mm  2  Basal lamina 
DM  0  - 
DM15  0.4  - 
DM~5  +  EEl0  250  + 
DM15  +  50  Ixg/ml L-ascorbic acid  280  + 
For the experiments reported in Tables I-VI, fully repopulated SC-neuron cul- 
tures grown in DM  were maintained for 2  wk in the medium indicated, and 
then fixed and stained with Sudan black, and myelin formation was quantitated 
as described in Materials and Methods.  Myelin segments/mm  2 values in all 
tables are averages of duplicate cultures for each medium tested. A  numeri- 
cal  subscript to  DM  (e.g.,  DM~5) indicates the  percent  serum;  all  serum- 
containing media in this table were made with HPS. EE followed by a number 
indicates the percent chick embryo extract. 
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on Schwann Cell Differentiation 
Medium  Myelin segments/ram  2  Basal lamina* 
DM  0  -- 
DMdl5  2.6  -- 
DMdl5  +  EEl5  290  + 
DMd~5  +  50  gg/ml L-ascorbic acid  250  + 
DMd15  +  EEl5  ultratiltrate,  no pretreatment 
DMd15 +  EEl5  ultratiltrate,  pretreated with 0.05  U/ml ascorbic acid oxidase 
DM-d~5 +  EEl5  ultrafiltrate,  pretreated with  1 mg/ml trypsin 
260  + 
6.0 
230  + 
SC-neuron cultures were grown and analyzed as described in Table I. A numerical subscript to DM preceded by d (e.g., DMals) indicates that serum dialyzed 
as described in Materials and Methods was used; all serum-containing media in this table were made with HPS.  Pretreatment and ultrafiltmtion of chick EE were 
performed as described in Materials and Methods. Chick EE treated  with 0.5 and 5 U/ml ascorbic acid oxidase stimulated the formation of 3.2 and 4.6 myelin 
segments/ram  2, respectively.  Other abbreviations used are given in Table I. 
* Basal lamina formation in these media is illustraled in Fig.  4. 
resulting in patterns of antibody staining indistinguishable 
from those observed for cultures grown in standard myelinat- 
ing medium (not shown). 
Medium  made  with  15%  dialyzed  HPS  (DMdts),  like 
DMt~, promoted neither significant myelin formation (Table 
II) nor the deposition of basal lamina components (Fig. 4 a). 
Similarly, the addition of either chick EE or ascorbic acid 
to DMdt5 was sufficient to stimulate maximal myelin forma- 
tion (Table II) and the deposition of  basal lamina components 
(Fig. 4, b and c). To confirm that ascorbic acid was the com- 
ponent responsible for the effects of  chick EE on SC differen- 
tiation, chick EE was first treated with ascorbic acid oxidase 
and then passed through a  10-kD cutoff membrane, and the 
ultrafiltrate was tested for its ability to promote SC differenti- 
ation in DMdt~. AS shown in Table II, chick EE ultrafiltrate 
which had been treated with ascorbic acid oxidase lacked the 
ability  to promote substantial  myelin formation,  whereas 
treatment with 1 mg/mi trypsin had little effect on such abil- 
ity. In addition, whereas untreated or trypsin-treated chick 
EE ultrafiltrate promoted normal basal  lamina formation, 
ascorbic acid oxidase-treated ultrafiltrate did not (Fig. 4, 
d-f). These results indicate that the active component of EE 
is ascorbic acid and that in the presence of ascorbic acid no 
dialyzable serum components are required for SC differenti- 
ation. In addition, they clearly illustrate the close correlation 
between conditions that promote basal lamina assembly and 
those that promote myelin formation. 
Since we wanted to avoid the use of human serum, FBS 
was tried as a substitute and found to have the same proper- 
ties as HPS. Medium made with 15% FBS (i.e., DMLs) was 
unable to promote myelin formation (Table HI). The addition 
of ascorbic acid to FBS DM15 resulted in myelination which 
was quantitatively the same as in equivalent HPS-containing 
medium and in standard myelinating medium. Furthermore, 
media made with dialyzed FBS had effects identical to their 
counterparts made with HPS; namely, DMdt~ failed to pro- 
mote myelin formation (Table HI) or basal lamina assembly 
(data not shown), whereas the effects of DMdt~ plus ascor- 
bic acid in promoting both myelin formation (Table III) and 
basal lamina assembly (Fig. 2, j-l) were indistinguishable 
from those of  similar HPS-containing media. In three experi- 
ments, FBS DMd~ plus ascorbic acid promoted the forma- 
tion of an average of 310 myelin segments/mm  2 (SEM  = 
15), whereas standard myelinating medium promoted an av- 
erage of 280 myelin segments/mm  2 (SEM  =  6). 
The ascorbic acid concentration dependence of  basal lam- 
ina assembly and of myelin formation was investigated using 
DM supplemented with FBS which had been dialyzed to re- 
move any endogenous ascorbic acid-like activity. As shown 
in Fig. 5, a doubting of the ascorbic acid concentration from 
8.5 to 17 pM led to a >200-fold increase in the quantity of 
myelin formed, and led to a change from essentially no basal 
lamina assembly (8.5 pM; Fig.  5 a) to the formation of a 
basal lamina (17 ~tM; Fig. 5 b) which was very similar to that 
formed with the standard ascorbic acid concentration of 50 
pg/mi (280 gM; Fig. 5 c). 
Several compounds related to ascorbic acid were tested for 
effects on basal lamina assembly and on myelin formation, 
in an attempt to determine whether it might be possible to 
promote one of these aspects of SC differentiation indepen- 
dently from the other. As shown in Fig. 5, all three ascorbic 
acid analogs tested were active in promoting myelin forma- 
tion in DlVId~, although they were considerably less active 
than ascorbic acid, with D-isoascorbic acid "o3-5 times less 
active and  L-ascorbic acid  2-sulfate and  dehydroascorbic 
acid ,o20-30 times less active. All three analogs were also 
active in promoting basal lamina assembly at the higher con- 
centrations that promoted myelin formation (Fig. 5, d-f), but 
at none of the concentrations of any analog tested were we 
able to obtain basal lamina formation without myelin forma- 
tion, or vice versa. Also tested were two other compounds, 
reduced glutathione and dihydroxyfumaric  acid, which share 
with ascorbic acid the ability to donate electrons to appropri- 
ate cellular acceptors. As shown in Fig. 5, neither compound 
had any myelination-promoting activity over the 1,000-fold 
concentration range tested, nor were they active in promot- 
ing basal lamina assembly (not shown). 
Some batches of HPS were found which had the anoma- 
lous property of being effective in promoting SC differentia- 
tion in the absence of chick EE or exogenous ascorbic acid. 
In medium made with such HPS, both basal lamina and my- 
elin formation were similar with or without chick EE or 
ascorbic acid supplements (Table IV). When such HPS was 
first dialyzed and then used to prepare DMde, its ability to 
stimulate SC myelin formation and the deposition of basal 
lamina components was lost, and could be restored by the ad- 
dition of either chick EE or ascorbic acid (Table IV). Fur- 
thermore, treatment of such HPS with ascorbic acid oxidase 
abolished its ability to promote myelination and basal lamina 
formation (Table IV). Finally, samples of HPS were directly 
The Journal of Cell Biology, Volume 105,  1987  1028 Figure 4. Effect of ascorbic acid oxidase and trypsin treatments on 
the ability of embryo extract to promote basal lamina formation 
by SCs grown with neurons.  Myelination  results  for the experi- 
ment illustrated  here are presented  in  Table H.  Cultures  were 
grown for two weeks  in  DM supplemented  with  15%  dialyzed 
HPS without additional additives (a), or with  15% chick EE (b), 
ascorbic acid (c), 15 % chick EE ultrafiltrate,  no pretreatment  (d), 
15%  chick  EE ultrafiltrate,  pretreated  with 0.05  U/ml ascorbic 
acid oxidase (e), or 15% chick EE ultrafiltrate,  pretreated  with  1 
mg/ml  trypsin  (f).  Living  cultures  were  stained  with  rabbit 
anti-NCl  followed  by  fluorescein  goat  anti-rabbit,  then  pho- 
tographed  and printed  identically.  Bar,  25 Itm. 
Table III. FBS Plus Ascorbic Acid Acts as a 
Differentiation-promoting Medium 
Myelin 
Medium  segments/nun  2  Basal lamina* 
DM  0  - 
DM15  0.1  - 
DM15  +  50  ttg/ml  L-ascorbic acid  310  + 
DMd15  0.2  - 
DMd~5  +  50  Ixg/ml L-ascorbic  acid  310  + 
SC-neuron  cultures were grown and analyzed as described in Table I.  All 
serum-containing media in this table were made with FBS. 
* Basal lamina formation in Dlv~s  +  A  is illustrated in Fig. 2. 
assayed for ascorbic acid, and the measured value, in con- 
junction with the ascorbic acid-myelin dose-response curve 
(Fig.  5),  was  used  to  calculate  the  expected myelin  seg- 
ments/mm  2 value.  As  shown  in  Table V,  batches  of HPS 
which exhibited the ability to promote myelination without 
other additives had  sufficient ascorbic acid to account for 
that ability. 
A Macromolecular Serum Factor Is Required to 
Enable Ascorbic Acid to Promote Normal 
Schwann Cell Differentiation 
In the  experiments reported above,  the  effects of ascorbic 
acid on SC differentiation were examined in the presence of 
serum.  Additional experiments revealed that supplementa- 
tion  of DM  with  ascorbic  acid  in  the  absence  of serum 
resulted in only partial promotion of SC differentiation. SCs 
responded to the ascorbic acid by tending to aggregate with 
one another on the surface of the axon network (Fig. 6 a); 
deposition of laminin, type IV collagen, and HSPG occurred 
in  the  presence  of ascorbic  acid  alone,  both  around  ag- 
gregated SCs and on SCs displaying apparently normal mor- 
phological differentiation (data not shown). The staining for 
these components was, however, considerably less intense 
and regular than when serum was added with the ascorbic 
acid. In addition,  myelin formation was observed to occur 
in the presence of ascorbic acid alone, but quantitatively it 
was small and variable compared to ascorbic acid plus FBS 
(average  for  three  experiments,  DM  =  0  myelin  seg- 
ments/mm  2  [SEM  =  0],  DM  plus  ascorbic  acid  =  22 
[SEM  =  16], and DMo~ plus ascorbic acid =  290 [SEM  = 
17]), and the myelin segments were abnormally short (Fig. 6). 
We tested several proteins for their ability to promote my- 
elination in the presence of ascorbic acid, and the results in- 
dicate that the requirement for serum with ascorbic acid is 
relatively specific in that it cannot be satisfied by bulk pro- 
tein, although a slight enhancement of myelin formation can 
be obtained with several different proteins. Media made with 
ascorbic acid plus BSA at the concentration of total protein 
in FBS DMdt5 (6.3 mg/ml), bovine transferrin at its concen- 
tration in DM_dt~, BSA plus transferrin, or rat transferrin at 
10 times the concentration in DM all promoted more myelin 
formation than did ascorbic acid alone, but none promoted 
myelin formation comparable to dialyzed FBS plus ascorbic 
acid (Table VI). In addition, in the presence of ascorbic acid 
plus  the  proteins  tested,  the  myelin remained abnormally 
short, extensive SC aggregation still occurred, and the depo- 
sition of basal lamina components was patchy. In a different 
experiment the addition of  45 gg/ml human plasma fibronec- 
tin  with  ascorbic  acid  failed to promote the  formation of 
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Figure 5. Dose-response curves for the stimulation of myelin and basal lam- 
ina formation by ascorbic acid and related compounds.  SC-neuron cultures 
were grown for 2 wk in DM supplemented with 15 % dialyzed FBS contain- 
ing the indicated concentration  of test compound,  and then processed  for 
myelin quantitation  or analysis of basal lamina  formation  as described  in 
Materials and Methods.  (Top) Dose-response curves for the stimulation of 
myelin formation by L-ascorbic acid (solid circles), ~isoascorbic acid (open 
squares),  dehydroascorbic  acid  (solid squares),  L-ascorbic acid  2-sulfate 
(open triangles), reduced glutathione (circles around solid triangles), or di- 
hydroxyfumaric acid (solid triangles). Letters (a-f) indicate points chosen for 
illustration (bottom) of the status of basal lamina formation. (Bottom) Analy- 
sis of basal lamina formation promoted by 8.5 (a),  17 (b),  or 280 (c) tiM 
L-ascorbic acid, 98 IxM o-isoascorbic acid (d), 850 laM L-ascorbic acid 2-sul- 
fate (e), or 1,420 ~tM dehydroascorbic acid (f). Living cultures were stained 
with mouse anti-HSPG followed by rhodamine goat anti-mouse,  then photo- 
graphed and printed identically. Bar, 50 tim. 
more myelin than ascorbic acid alone (data not shown). Pre- 
vious reports (Carey, 1983;  Eldridge et al.,  1984) have sug- 
gested  that  fetuin,  an  FBS  protein,  might be an effective 
agent for promoting  SC differentiation  in  the presence of 
ascorbic acid.  We found, however, that the effect of fetuin 
(1 mg/ml) plus ascorbic acid was relatively small and vari- 
able  (65  myelin  segrnents/mm  2,  SEM  =  31,  average  of 
three experiments), in comparison with standard myelinating 
medium (300 myelin segrnents/mm  2,  SEM  =  11). 
Discussion 
Obtaining peripheral nervous system myelination in vitro has 
traditionally required the use of the complex medium addi- 
tives HPS and chick EE (Murray et al.,  1965;  Bunge et al., 
1967;  Moya et al.,  1980).  The experiments reported here 
substantially explain the role of chick EE. The sole activity 
of chick EE important for SC myelin formation appears to 
be ascorbic acid; the activity was dialyzable, insensitive to 
trypsin, sensitive to ascorbic aci;t oxidase, and replaceable 
by ascorbic acid.  The ability of some batches  of HPS  to 
stimulate myelination in the absence of other additives ap- 
pears to be due to endogenous ascorbic acid; the measured 
ascorbic acid concentration accounted for the ability of such 
sera to promote myelination, and ascorbic acid oxidase treat- 
ment abolished the  myelination-promoting effects of such 
sera. 
These experiments also demonstrate that  SCs  require  a 
macromolecular serum factor(s) in addition to ascorbic acid 
Table IV. Some Sera Alone Promote Schwann Cell 
Differentiation Because They Contain Endogenous 
Ascorbic Acid-like Activity 
Myelin  Basal 
Medium  segments/ram  ~  lamina 
DM  0  - 
DMI5  280  + 
DM~5  +  EEl5  290  + 
DM~5  +  50  ~tg/ml L-ascorbic acid  280  + 
DM]5,  pretreated with 5  U/ml  1.2  - 
ascorbic acid oxidase 
DMdl5  2.6  - 
DMa15  +  EEl5  290  + 
DMaI5  +  50 I.tg/ml L-ascorbic acid  250  + 
SC-neuron cultures were grown and analyzed as described in Table I.  All 
serum-containing  media in this table were made with HPS.  Some HPS was in- 
cubated with 5 U/ml ascorbic acid oxidase for 1 h at pH 7, room temperature, 
and then used to make DM~5. 
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with Ability to Promote Myelin Formation 
Serum 
Measured  Myelin segments/mm  2 
concentration 
in DMIs  Expected  Observed 
/.tM 
HPSI  13.1  170  210 
dHPSI  1.2  <1  0.1 
HPS2  2.3  <1  0.5 
HPS3  3.7  <1  0.6 
HPS4  13.2  175  160 
driPS4  0.9  < 1  0 
FBSl  2.1  <1  0.1 
FBS2  0.6  <1  0.2 
dFBS2  0.5  <1  0.5 
SC-neuron cultures were grown and analyzed  as described in Table I. A serum 
abbreviation preceded by d indicates that the serum had been dialyzed. Sera 
were assayed for ascorbic acid concentration as described in Materials and 
Methods. The ascorbic acid concentration achieved in DM~ medium was 
then calculated and used, in conjunction with the ascorbic acid-myelin dose- 
response curve in Fig. 6, to calculate the number of myelin segments/mm  2 
that would be expected to be formed in that medium. 
for  maximum  expression  of their  potential  to  myelinate 
axons in this culture system. Ascorbic acid in the absence of 
serum stimulated the formation of small quantities of myelin, 
but also elicited abnormal  SC  behavior (aggregation with 
other SCs). Substitution for serum with other proteins, such 
as BSA or transferrin, fetuin, or fibronectin failed to enable 
ascorbic acid to promote the formation of  myelin in the quan- 
tities observed in the presence of serum, thus suggesting that 
the activity of serum may be due to a specific macromolecu- 
lar component. 
The experiments reported here additionally demonstrate 
that SC basal lamina formation has requirements identical to 
SC myelin formation, namely ascorbic acid and a nondialyz- 
able serum component. Without exception, media that pro- 
Table VI. Serum Is a Specific Requirement for the 
Promotion of  Myelination  by Ascorbic Acid 
Myelin 
Medium  segments/ram  2 
DM  0 
DM  +  50 txg/ml  L-ascorbic acid  6.4 
DM  +  50  gg/ml L-ascorbic acid  + 
6.3 mg/ml BSA  28 
DM  +  50  ~tg/ml L-ascorbic acid  +  250  Ixg/ml 
bovine transferrin  18 
DM  +  50  I~g/ml L-ascorbic acid  +  BSA  + 
bovine transferrin  51 
DM  +  50  Ixg/ml L-ascorbic acid  +  100 lxg/ml 
rat transferrin  15 
DM  +  50 Itg/ml L-ascorbic acid  + 
15%  dialyzed FBS  310 
SC-neuron cultures were grown and analyzed  as described in Table I. 
moted myelin formation also promoted basal lamina forma- 
tion, and vice versa. This correlation persisted through the 
various manipulations of sera and chick EE, and with ana- 
logs of ascorbic acid. Perhaps the most striking example of 
this correlation was provided by an examination of the ascor- 
bic acid concentration dependence of  these two aspects of SC 
differentiation, in which a doubling of the ascorbic acid con- 
centration from 8.5 to 17 uM in the presence of dialyzed se- 
rum led to a change from the absence of basal lamina and 
myelin formation to the formation of both in a manner simi- 
lar to that obtained in control myelinating media. 
Ascorbic acid appears to be a specific requirement for SC 
differentiation. The concentration at which ascorbic acid was 
active in promoting both basal lamina and myelin formation 
by SCs is similar to the range over which it is active in vitro 
in promoting collagen production by human skin fibroblasts 
(Murad et al., 1983), collagen deposition by rat smooth mus- 
Figure 6.  Comparison of the effects of ascorbic acid in the absence (a) or presence (b) of 15 % dialyzed FBS. SC-neuron cultures were 
grown for 2 wk in these media and then fixed and stained with Sudan black. In the absence of serum, ascorbic acid predominantly causes 
SCs to migrate into aggregates (curved arrows), but also promotes the formation of occasional short myelin segments (arrowheads). 
Bar,  50  ltm. 
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number of acetylcholine receptors  on myogenic L5  cells 
(Knaack and Podleski, 1985). Our findings that nonascorbic 
acid reducing agents had no activity in promoting either as- 
pect of SC differentiation studied mean that it is unlikely that 
ascorbic acid is required simply as a general source of reduc- 
ing activity. Our findings that all of the analogs of ascorbic 
acid tested were active in promoting SC differentiation are 
attributable to the ability of  the analogs to be convertexl enzy- 
matically to ascorbic acid within the cell (dehydroascorbic 
acid,  Tolbert and Ward,  1982; L-ascorbic acid 2-sulfate, 
Benitez and Halver, 1982) or to directly substitute for ascor- 
bic acid as an enzymatic cofactor (D-isoascorbic  acid; Hut- 
ton et al., 1967; Kutnink et al., 1969). The relative activities 
of the analogs in stimulating basal lamina and myelin forma- 
tion by SCs were similar to those reported for functions of 
other cell types (Murad et al., 1983; Knaack and Podleski, 
1985). 
In our experiments the serum factor(s) alone had essen- 
tially no effects on SC differentiation, whereas ascorbic acid 
alone promoted some myelin and basal lamina formation. In 
the presence of the  serum factor, however,  ascorbic acid 
stimulated myelin formation which was quantitatively supe- 
rior to that in the absence of the serum factor; in addition, 
basal lamina formation was much more uniform. The serum 
factor might simply serve to protect the ascorbic acid from 
oxidation (Mishra and Kovachich, 1983),  thus maintaining 
an adequate medium concentration for a  longer period of 
time. Alternatively, the serum factor might (a) be either a 
protease inhibitor or a  protease which could affect either 
basal lamina formation or SC-axon interactions (e.g., plas- 
minogen; Kalderon, 1979); (b) act as, or allow expression of, 
a ligand for an as yet unidentified type of SC-axon interac- 
tion requisite for the process of myelination; or (c) act as a 
progression factor for SC differentiation. 
Although the exact roles played by ascorbic acid and the 
macromolecular serum factor(s) in stimulating SC differenti- 
ation are not known, there is evidence that neither ascorbic 
acid nor the serum factor is directly required for the process 
of myelin formation. Oligodendrocytes, the central nervous 
system myelin-forming  cells, myelinate axons in this culture 
system equally well in DM and DM supplemented with as- 
corbic acid and/or serum (Eldridge et al., 1987). This result 
suggests that the failure of SCs to form myelin in DM is not 
due to the failure of the neurons to express the signal for my- 
elination on their axons, and further indicates that unsup- 
plemented DM is a  sufficient source of precursors for the 
biosynthesis of the myelin lipids, glycolipids, and glycopro- 
teins which oligodendrocytes and SCs have in common. Di- 
rect evidence that SCs do not require either ascorbic acid or 
serum to synthesize and assemble myelin comes from experi- 
ments in which exogenous basal lamina was shown to be 
sufficient to allow SCs to myelinate axons in DM (Carey et 
al.,  1986; Eldridge,  1986). 
We hypothesize that ascorbic acid acts to promote SC my- 
elin formation in an indirect manner, by directly enabling the 
SC to assemble a basal lamina around itself. Under this hy- 
pothesis a basal lamina is required for the SC to generate the 
plasma  membrane  polarity  and  cytoskeletal organization 
needed to execute the complex shape changes which myelin 
formation requires. This hypothesis emphasizes the epithe- 
lial nature of  the differentiated SC, its membrane being func- 
tionally polarized into basal lamina- and axon-facing do- 
mains, and is based on the known influences of extracellular 
matrices on the polarity (Chambard et al., 1981; Montesano 
et al., 1983), cytoskeleton (Sugrue and Hay,  1981), and dif- 
ferentiation (Hadley et al.,  1985) of epithelial cells. 
This interpretation of our results is supported by the fol- 
lowing evidence to be presented in the second paper in this 
series (Eldridge,  1986; Eldridge, C. E, M. B. Bunge, and 
R. P. Bunge, manuscript in preparation).  (a) Oligodendro- 
cytes, which do not form a basal lamina, show no require- 
ment for ascorbic acid in order to myelinate axons in our cul- 
ture system. (b)  Exogenous basal lamina provided to SCs 
grown with neurons in DM is sufficient to allow the forma- 
tion of  myelin in quantities equal to those formed in DM sup- 
plemented with ascorbic acid plus serum, whereas exoge- 
nous interstitial extracellular matrix is not. (c) Finally, SCs 
grown with neurons in the absence of ascorbic acid do not 
secrete native, triple-helical collagen molecules, although 
they secrete a  repertoire of other proteins very similar to 
those secreted by differentiated SCs, and, as shown in this 
paper,  they express both laminin and HSPG on their sur- 
faces. 
Ascorbic acid is known to be an important participant 
in the  posttranslational hydroxylation of collagen proline 
residues; hydroxyproline is essential for collagen chains to 
associate into triple helices, thereby forming native collagen 
molecules (for reviews see Prockop et al.,  1976; Kivirikko 
and Myllyla, 1982). It is known that the interactions between 
type IV collagen, laminin, and HSPG (Woodley et al., 1983; 
Kleinman et al., 1983; Fujiwara et al., 1984), which may be 
important in the formation of a basal lamina, require native 
type IV collagen (Kleinman et al., 1983), and it may be that 
ascorbic acid promotes SC myelin formation by allowing the 
SC to assemble a  basal lamina stabilized by triple-helical 
type IV collagen. 
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Note Added in Proof'. Carey and Todd (Carey,  D. J., and M. S. Todd, 1987 
Dev.  Brain Res.  32:95-102) recently reported that BSA and fetuin were as 
effective as serum in enabling ascorbic acid to fully promote SC myelina- 
tion, suggesting that the serum requirement is nonspecific. Our data on the 
effect of fetuin and BSA on myelination agree well with those of Carey and 
Todd, in that these proteins (in the presence of ascerbic acid) promoted the 
formation of 30-65 myelin segment~mm  2.  Our positive control for my- 
elination (15 % dialyzed serum plus ascorbic acid), however, consistently 
yielded values of ,0300 segments/mm  2, whereas that of Carey and Todd 
(10% serum plus 5% chick EE) promoted only 18 segments/mm  2. Given 
the possibility of variability  in endogenous ascorbic acid levels in  the 
undefined EE and serum components (see Table V), it seems likely that the 
positive control of Carey and Todd had insufficient ascorbic acid levels to 
promote maximal myelination. Recent preliminary experiments we have 
done show that dialyzed plasma-derived serum is as effective as dialyzed 
whole blood serum in enabling ascorbic acid to fully promote myelination, 
suggesting that the active factor(s) in serum is not platelet derived. 
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